Curable compositions based on multistage polymers

Patent metadata

Field	Value
Publication number	US-12084571-B2
Application number	US-201917253852-A
Country	US
Kind code	B2
Filing date	May 7, 2019
Priority date	Jun 26, 2018
Publication date	Sep 10, 2024
Grant date	Sep 10, 2024

Abstract

Compositions which are curable by, for example, exposure to radiation to form useful articles such as three-dimensionally printed objects are prepared using multistage polymers, polymerizing organic substances and (meth)acrylic polymers. The multistage polymer is effective to toughen and impact modify the cured articles, yet the compositions prior to curing are relatively low in viscosity and agglomerate content even at high loadings of multistage polymer.

First claim

The invention claimed is:

1. A curable composition comprising component (a), component (b), component (c), and optionally component (d), wherein:
a) component (a) is one or more multistage polymers;
b) component (b) is one or more (meth)acrylic polymers (P1), which is or are the same or different in composition from any (meth)acrylic polymer present as part of the multistage polymer(s) of component (a);
c) component (c) is one or more polymerizing organic substances selected from the group consisting of tetrahydrofurfuryl methacrylate, cyclic trimethylolpropane formal acrylate, methoxy polyethylene glycol monomethacrylates containing on average from about 6 to about 15 ethylene oxide units, polyethylene glycol dimethacrylates containing from about 3 to about 7 ethylene oxide units, 1,4-butanediol dimethacrylate, trimethylolpropane trimethacrylate, ethoxylated pentaerythiritol tetraacrylates containing from about 2 to about 6 ethylene oxide units, hydroxypropyl methacrylate, ethoxylated bisphenol A dimethacrylates containing from about 1 to about 12 ethylene oxide units, tricyclodecanemethanol acrylate, dicyclodecane dimethananol diacrylate, (meth)acrylate-functionalized urethane oligomers and combinations thereof; and
d) optional component (d) is one or more photoinitiators.

2. The curable composition of claim 1 , wherein component (a) includes at least one multistage polymer selected from the group consisting of:
i) multistage polymers comprising:
A) an (A) stage polymer comprising a polymer (A1) having a glass transition temperature of less than 0° C.; and
B) a (B) stage polymer comprising a polymer (B1) having a glass transition temperature of at least 30° C.; and

ii) multistage polymers comprising:
A) an (A) stage polymer comprising a polymer (A1) having a glass transition temperature of less than 10° C.;
B) a (B) stage polymer comprising a polymer (B1) having a glass transition temperature of at least 60° C.; and
C) a (C) stage polymer comprising a polymer (C1) having a glass transition temperature of at least 30° C., wherein the (C) stage polymer may provide at least a part of component (b).

3. The curable composition according to claim 2 , wherein the (A) stage polymer is grafted onto the (B) stage polymer.

4. The curable composition according to claim 2 , wherein polymers (A1) and (B1) are (meth)acrylic polymers which have compositions which are different from that of (meth)acrylic polymer(s) (P1).

5. The curable composition according to claim 1 , wherein the one or more (meth)acrylic polymers (P1) are soluble at 25° C. in component (c).

6. The curable composition according to claim 1 , wherein the one or more (meth)acrylic polymers (P1) comprise at least 50 wt % methyl methacrylate.

7. The curable composition according to claim 1 , wherein component (b) has a glass transition temperature of at least 30° ° C.

8. The curable composition according to claim 2 , wherein polymer (A1) is a polyorganosiloxane or comprises at least 50 wt % of polymeric units coming from isoprene or butadiene.

9. The curable composition according to claim 1 , wherein the one or more (meth)acrylic polymers (P1) of component (b) are not grafted on the one or more multistage polymers of component (a).

10. The curable composition of claim 1 , wherein component (c) has a Hansen solubility parameter δ tot of from 18.7 MPa 1/2 to 21.9 MPa 1/2 at 25° C.

11. The curable composition of claim 1 , wherein component (c) has at least one of a δ p value of from 9 MPa 1/2 to 13 MPa 1/2 at 25° C., a δ h value of from 4 MPa 1/2 to 11 MPa 1/2 at 25° C., or a δ d value of 12.9 MPa 1/2 to 16.9 MPa 1/2 at 25° C.

12. A curable composition comprising component (a), component (b), component (c), and optionally component (d), wherein:
a) component (a) is one or more multistage polymers;
b) component (b) is one or more (meth)acrylic polymers (P1), which is or are the same or different in composition from any (meth)acrylic polymer present as part of the multistage polymer(s) of component (a);
c) component (c) is one or more polymerizing organic substances comprising at least one polymerizing flexibilizer selected from the group consisting of (meth)acrylate-functionalized urethane oligomers, (meth)acrylate-functionalized polyester oligomers, (meth)acrylate-functionalized polyether oligomers, epoxy-functionalized oligomers and combinations thereof;
d) optional component (d) is one or more photoinitiators.

13. The curable composition of claim 1 , wherein component (d) includes at least one photoinitiator selected from the group consisting of free radical photoinitiators, cationic photoinitiators and combinations thereof.

14. The curable composition of claim 1 , additionally comprising at least one additive selected from the group consisting of stabilizers, light blockers, pigments and dyes.

15. The curable composition of claim 1 , comprising 0.5 to 25 wt % component (a), 5 to 80 wt % component (b), 10 to 95 wt % component (c), and 0.1 to 10 wt % component (d), wherein the sum of weights of (a), (b), (c) and (d) equals 100% in total.

16. The curable composition of 1 , wherein the composition has a content of component (a) of at least 10 wt % and a viscosity at 25° C. of not greater than 10,000 mPa·s (cP).

17. A masterbatch which is useful for preparing a curable composition in accordance with claim 1 , wherein the masterbatch comprises the components (a), (b) and (c) but has a higher concentration of component (a)+component (b) (sum of (a)+(b)) than the curable composition to be prepared from said masterbatch by further dilution with at least one component (c).

18. A method of making a curable composition in accordance with claim 1 , comprising combining a masterbatch with at least a quantity of component (c), wherein the masterbatch has a higher concentration of component (a) and component (b) than the curable composition to be prepared from the masterbatch.

Assignees

• Arkema France

Inventors

• Gupta Manjuli
• Bonhoure Lucile

Classifications

• B29K2033/00

  Use of polymers of unsaturated acids or derivatives thereof as moulding material {(B29K2035/00 takes precedence)} · CPC title

• B29C64/124

  using layers of liquid which are selectively solidified · CPC title

• C08L75/16

  having terminal carbon-to-carbon unsaturated bonds · CPC title

• C08L71/02

  Polyalkylene oxides · CPC title

• C08F222/103

  of trialcohols, e.g. trimethylolpropane tri(meth)acrylate · CPC title